Leech, P. N.: Relation of the Food Drug and Cosmetic Act to the Work of the Council on Pharmacy and Chemistry and Manufacturing Pharmacy , read at the twenty-eighth annual meeting of the American Drug Manufacturers Association, Hot Springs, Va., May 1, 1939 .
Hanzlik, P. J., assignor to Board of Trustees of Stanford University of California: Antisyphilitic Preparation and Process of Manufacture, U. S. Patent Office, Pat. No. 2,125,561, Aug. 2, 1938.
Hanzlik, P. J.; Lehman. A. J., and Richardson, A. P.: Sodium Bismuthate Soluble , Am. J. Syph., Gonor. & Ven. Dis. 21:1 (
(Jan.)
) 1937;.
Sollmann, Torald; Cole, Harold, and Henderson, Katherine: Clinical Excretion of Bismuth: V. Excretion of Sobisminol and Some Other Bismuth Preparations for Oral Administration ,
Arch. Dermat. & Syph. 37:993 (
(June)
) 1938;.
Link to Article[[XSLOpenURL/10.1001/archderm.1938.01480120059010]]
Hanzlik, P. J.; Lehman, A. J.; Richardson, A. P., and Van Winkle, W., Jr.: Clinical Excretion of Bismuth After Oral Administration of Sobisminol ,
Arch. Dermat. & Syph. 36:708 (
(Oct.)
) 1937;.
Link to Article[[XSLOpenURL/10.1001/archderm.1937.01480040025002]]
Sodium bismuthate is such a "strong" oxidizing agent that it could not have existed in such a mixture as proposed without rapidly oxidizing the other substances present.
Hanzlik, Lehman and Richardson, footnotes 2 and 21.
Hanzlik, P. J.; Lehman, A. J., and Richardson. A. P.: Intramuscular Injection of Sobisminol: Absorption and Distribution of Bismuth , J. Pharmacol. & Exper. Therap. 62:413 (
(April)
) 1938;.
Hanzlik, Lehman and Richardson, footnotes 2 and 7.
Hanzlik, P. J.; Lehman, A. J.; Richardson, A. P., and Van Winkle, W., Jr.: Rapid Clinical Method for the Estimation of Bismuth in Urine ,
Arch. Dermat. & Syph. 36:725 (
(Oct.)
) 1937;.
Link to Article[[XSLOpenURL/10.1001/archderm.1937.01480040042003]]
Hanzlik and others, footnotes 2 and 11.
Hanzlik, P. J.; Lehman, A. J.; Richardson, A. P., and Van Winkle, W., Jr.: Gastrointestinal Administration of Sobisminol: Absorption, Distribution and Excretion of Bismuth , J. Pharmacol. & Exper. Therap. 62:54 (
(Jan.)
) 1938;.
Hanzlik and others, footnotes 2, 4 and 20. Sollmann, Cole and Henderson.3
Sollmann, Torald, and Henderson, Katherine: Bismuth Studies: VII. Bismuth Distribution in Dogs Following Intramuscular Injection of a Single Dose of Various Bismuth Preparations , Am. J. Syph., Gonor. & Ven. Dis. 22:739 (
(Nov.)
) 1938;.
Hanzlik, Lehman and Richardson.20 Meininger and Barnett.25 Scholtz, McEachern and Wood.26
Hanzlik, Lehman and Richardson, footnotes 2 and 20. Sollmann, Cole and Henderson, footnotes 3 and 30. Meininger and Barnet.25 Scholtz, McEachern and Wood.26
Hanzlik, Lehman and Richardson, footnotes 2 and 20.
Stratton, Ernest K.: The Absorption and Elimination of Bismuth Following Its Oral Administration to Rabbits , Am. J. Syph., Gonor. & Ven. Dis. 22:728 (
(Nov.)
) 1938;.
Hanzlik and others, footnotes 2 and 4.
Sollmann, Cole and Henderson.3 Hanzlik, Lehman and Richardson.20
Hanzlik, P. J.; Lehman, A. J., and Richardson, A. P.: Excretion of Bismuth After Intramuscular Injection of Sobisminol: Experimental and Clinical Results , J. Pharmacol. & Exper. Therap. 62: 404 (
(April)
) 1938;.
Hanzlik, P. J.; Lehman, A. J., and Richardson, A. P.: Sobisminol: Toxicity, Tolerance and Irritation According to Different Channels of Administration , J. Pharmacol. & Exper. Therap. 62:372 (
(April)
) 1938;.
Hanzlik and others, footnotes 2 and 24.
Lehman. A. J., and Dock, W.: Effects of Drinking Sobisminol on Skeletal Changes in Growing White Rats , J. Pharmacol. & Exper. Therap. 63:88 (
(May)
) 1938;.
Hanzlik, P. J., and Lehman, A. J.: Continued Voluntary Drinking of Sobisminol: General Effects , J. Pharmacol. & Exper. Therap. 62: 389 (
(April)
) 1938;.
Meininger, W. M., and Barnett, C. W.: The Treatment of Syphilis with Sobisminol Mass Given by Mouth, this issue, p. 2214.
Scholtz, J. R.,; McEachern, Katherine D., and Wood, Clyde: Sobisminol Mass Clinical Results with Oral Administration, this issue, p. 2219.
Hanzlik, P. J.: Sodium Bismuthate Soluble in Experimental Syphilis , J. Pharmacol. & Exper. Therap. 59: 328 (
(March)
) 1937;.
Sollmann, Cole and Henderson, footnotes 3 and 30.
Kay, Willard E., and Fricke, John W.: Sobisminol: Its Oral Administration , California & West. Med. 50:348 (
(May)
) 1939;.
Sollmann, Torald; Cole, Harold, and Henderson, Katherine: Combination Courses of Bismuth Administration ,
J. A. M. A. 111: 2175 (
(Dec.)
) 1938;.
Link to Article[[XSLOpenURL/10.1001/jama.1938.02790500013004]]
Beckh, Walter, and Barnett, C. W.: The Effect in Early Syphilis of Combined Treatment in Comparison with Alternating Treatment ,
Arch. Int. Med. 63:974 (
(May)
) 1939;.
Link to Article[[XSLOpenURL/10.1001/archinte.1939.00180220164015]]
Meininger and Barnett.25 Scholtz, McEachern and Wood.26
In this connection it may be pointed out that the licensees have made the following agreement with Stanford University: "Neither Licensee nor his agents, in carrying out the sale and distribution of said products shall: (a) Furnish to retailers or condone or encourage use by retailers of any counter advertising or counter displays of said products; (b) Advertise said products directly to the public by advertisements in magazines or newspapers of general circulation or by printed circulars distributed to the general public; (c) Condone or encourage in any way 'over the counter' sales of said products to the public except through licensed pharmacists or prescriptions of licensed physicians. Licensee shall use its best efforts to maintain distribution of said products exclusively through licensed pharmacists on prescription of licensed physicians, and to prevent over the counter sales of said product to the public."